EMERYVILLE, Calif., Jan. 8 /PRNewswire-FirstCall/ --
Chiron Corporation (Nasdaq: CHIR) today announced that it will present at the
JPMorgan 20th Annual Healthcare Conference. The presentation will begin at
9:30 a.m. Pacific Standard Time (PST), Thursday, January 10, 2002. Investors
may access a live audio webcast of the presentation and slide materials at
http://www.chiron.com . We recommend logging on 15 minutes early in order to
register and download any necessary software.
About Chiron
Chiron Corporation, headquartered in Emeryville, California, is a leading
biotechnology company that participates in three global healthcare markets:
biopharmaceuticals, vaccines, and blood testing. The company is applying an
integrated scientific approach to the development of innovative products for
preventing and treating cancer and infection. For more information about
Chiron, visit the company's web site at http://www.chiron.com .
This news release contains forward-looking statements that involve risks
and uncertainties. A full discussion of the company's operations and
financial condition, including factors that may affect its business and future
prospects, is contained in documents the company files with the SEC, such as
form 10-Q and 10-K. These documents identify important factors that could
cause the company's actual performance to differ from current expectations,
including the outcome of clinical trials, regulatory review, manufacturing
capabilities and marketing effectiveness.
In line with the new SEC Rule FD, Chiron Corporation does not undertake an
obligation to update the forward-looking information we are giving today.
SOURCE Chiron Corporation
 back to top
Related links:
http://www.chiron.com
CONTACT:
John Gallagher, Media Relations Manager,
Corporate Communications & Investor Relations of Chiron
Corporation, +1-510-923-6905
|
